PMID- 33526590 OWN - NLM STAT- MEDLINE DCOM- 20210824 LR - 20220503 IS - 1939-327X (Electronic) IS - 0012-1797 (Print) IS - 0012-1797 (Linking) VI - 70 IP - 5 DP - 2021 May TI - Deficits in the Skeletal Muscle Transcriptome and Mitochondrial Coupling in Progressive Diabetes-Induced CKD Relate to Functional Decline. PG - 1130-1144 LID - 10.2337/db20-0688 [doi] AB - Two-thirds of people with type 2 diabetes mellitus (T2DM) have or will develop chronic kidney disease (CKD), which is characterized by rapid renal decline that, together with superimposed T2DM-related metabolic sequelae, synergistically promotes early frailty and mobility deficits that increase the risk of mortality. Distinguishing the mechanisms linking renal decline to mobility deficits in CKD progression and/or increasing severity in T2DM is instrumental both in identifying those at high risk for functional decline and in formulating effective treatment strategies to prevent renal failure. While evidence suggests that skeletal muscle energetics may relate to the development of these comorbidities in advanced CKD, this has never been assessed across the spectrum of CKD progression, especially in T2DM-induced CKD. Here, using next-generation sequencing, we first report significant downregulation in transcriptional networks governing oxidative phosphorylation, coupled electron transport, electron transport chain (ETC) complex assembly, and mitochondrial organization in both middle- and late-stage CKD in T2DM. Furthermore, muscle mitochondrial coupling is impaired as early as stage 3 CKD, with additional deficits in ETC respiration, enzymatic activity, and increased redox leak. Moreover, mitochondrial ETC function and coupling strongly relate to muscle performance and physical function. Our results indicate that T2DM-induced CKD progression impairs physical function, with implications for altered metabolic transcriptional networks and mitochondrial functional deficits as primary mechanistic factors early in CKD progression in T2DM. CI - (c) 2021 by the American Diabetes Association. FAU - Bittel, Daniel C AU - Bittel DC AUID- ORCID: 0000-0001-7951-1900 AD - Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO dcbittel@wustl.edu. FAU - Bittel, Adam J AU - Bittel AJ AD - Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO. FAU - Varadhachary, Arun S AU - Varadhachary AS AD - Department of Neurology, Washington University School of Medicine, St. Louis, MO. FAU - Pietka, Terri AU - Pietka T AD - Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO. FAU - Sinacore, David R AU - Sinacore DR AD - Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO. AD - Department of Physical Therapy, Congdon School of Health Sciences, High Point University, High Point, NC. LA - eng SI - figshare/10.2337/figshare.13643477 GR - F31 DK109649/DK/NIDDK NIH HHS/United States GR - T32 HD007434/HD/NICHD NIH HHS/United States GR - UL1 TR002345/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20210201 PL - United States TA - Diabetes JT - Diabetes JID - 0372763 RN - 0 (Electron Transport Chain Complex Proteins) SB - IM MH - Animals MH - Diabetes Mellitus, Type 2/*metabolism/pathology MH - Electron Transport Chain Complex Proteins/genetics/*metabolism MH - Humans MH - Mitochondria/*metabolism MH - Muscle, Skeletal/*metabolism MH - Renal Insufficiency, Chronic/*metabolism/pathology MH - Transcriptome/*genetics PMC - PMC8173802 EDAT- 2021/02/03 06:00 MHDA- 2021/08/25 06:00 PMCR- 2022/05/01 CRDT- 2021/02/02 06:02 PHST- 2020/07/02 00:00 [received] PHST- 2021/01/25 00:00 [accepted] PHST- 2021/02/03 06:00 [pubmed] PHST- 2021/08/25 06:00 [medline] PHST- 2021/02/02 06:02 [entrez] PHST- 2022/05/01 00:00 [pmc-release] AID - db20-0688 [pii] AID - 200688 [pii] AID - 10.2337/db20-0688 [doi] PST - ppublish SO - Diabetes. 2021 May;70(5):1130-1144. doi: 10.2337/db20-0688. Epub 2021 Feb 1.